1.Dellit, TH, Owens, RC, McGowan, JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44(2):159–177.
2.Strategy for the Control of Antimicrobial Resistance in Ireland (SARI). Guidelines for antimicrobial stewardship in hospitals in Ireland. Hospital Antimicrobial Stewardship Working Group Web site. http://www.hpsc.ie/hpsc/. Accessed June 17, 2010.
3.Guerra, CM, Pereira, CA, Neves Neto, AR, Cardo, DM, Correa, L. Physicians' perceptions, beliefs, attitudes, and knowledge concerning antimicrobial resistance in a Brazilian teaching hospital. Infect Control Hosp Epidemiol 2007;28(12):1411–1414.
4.Giblin, TB, Sinkowitz-Cochran, RL, Harris, PL, et al. Clinicians' perceptions of the problem of antimicrobial resistance in health care facilities. Arch Intern Med 2004;164(15):1662–1668.
5.Cabana, MD, Rand, CS, Powe, NR, et al. Why don't physicians follow clinical practice guidelines? a framework for improvement. JAMA 1999;282(15):1458–1465.
6.Abboud, PA, Cabana, MD. Understanding barriers to the adoption of clinical decision rules. Ann Emerg Med 2001;38(6):703–704.
7.Antoine, TL, Curtis, AB, Blumberg, HM, et al. Knowledge, attitudes, and behaviors regarding piperacillin-tazobactam prescribing practices: results from a multicenter study. Infect Control Hosp Epidemiol 2006;27(11):1274–1277.
8.Srinivasan, A, Song, X, Richards, A, Sinkowitz-Cochran, R, Cardo, D, Rand, C. A survey of knowledge, attitudes, and beliefs of house staff physicians from various specialties concerning antimicrobial use and resistance. Arch Intern Med 2004;164(13):1451–1456.
9.Wester, CW, Durairaj, L, Evans, AT, Schwartz, DN, Husain, S, Martinez, E. Antibiotic resistance: a survey of physician perceptions. Arch Intern Med 2002;162(19):2210–2216.
10.Miller, BA, Chen, LF, Sexton, DJ, Anderson, DJ. The impact of hospital-onset healthcare facility associated (HO-HCFA) Clostridium difficile infection (CD1) in community hospitals: surpassing methicillin-resistant Staphylococcus aureus (MRSA) as the new superbug. Paper presented at: Fifth Decennial International Conference on Healthcare-Associated Infections; March 20, 2010; Atlanta. Abstract 386.
11.Martin, SJ, Micek, ST, Wood, GC. Antimicrobial resistance: consideration as an adverse drug event. Crit Care Med 2010;38(suppl 6):S155–S161.
12.Dubberke, ER, Gerding, DN, Classen, D, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29(suppl 1):S81–S92.
13.Gould, IM. Antibiotic resistance: the perfect storm. Int J Antimicrob Agents 2009;34(suppl 3):S2–S5.